Page last updated: 2024-08-26

sr141716 and Hormone-Dependent Neoplasms

sr141716 has been researched along with Hormone-Dependent Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adhami, VM; Afaq, F; Mukhtar, H; Sarfaraz, S	1
Bifulco, M; Bisogno, T; De Petrocellis, L; Di Marzo, V; Laezza, C; Melck, D; Orlando, P	1

Other Studies

2 other study(ies) available for sr141716 and Hormone-Dependent Neoplasms

Article	Year
Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer research, 2005, Mar-01, Volume: 65, Issue:5 Topics: Adenocarcinoma; Apoptosis; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Dose-Response Relationship, Drug; Humans; Male; Morpholines; Naphthalenes; Neoplasms, Hormone-Dependent; Piperidines; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Androgen; Rimonabant; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2005
Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology, 2000, Volume: 141, Issue:1 Topics: Arachidonic Acids; Binding Sites; Blotting, Western; Breast Neoplasms; Cannabinoid Receptor Modulators; Cannabinoids; Cell Division; Endocannabinoids; Female; Glycerides; Humans; Male; Neoplasms, Hormone-Dependent; Nerve Growth Factors; Piperidines; Polyunsaturated Alkamides; Prostatic Neoplasms; Pyrazoles; Receptor Protein-Tyrosine Kinases; Receptors, Cannabinoid; Receptors, Drug; Receptors, Nerve Growth Factor; Receptors, Prolactin; Rimonabant; Tumor Cells, Cultured	2000

Article

Year

Cannabinoid receptor as a novel target for the treatment of prostate cancer.

Cancer research, 2005, Mar-01, Volume: 65, Issue:5

Topics: Adenocarcinoma; Apoptosis; Benzoxazines; Calcium Channel Blockers; Cannabinoids; Dose-Response Relationship, Drug; Humans; Male; Morpholines; Naphthalenes; Neoplasms, Hormone-Dependent; Piperidines; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Androgen; Rimonabant; RNA, Messenger; Time Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2005

Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.

Endocrinology, 2000, Volume: 141, Issue:1

Topics: Arachidonic Acids; Binding Sites; Blotting, Western; Breast Neoplasms; Cannabinoid Receptor Modulators; Cannabinoids; Cell Division; Endocannabinoids; Female; Glycerides; Humans; Male; Neoplasms, Hormone-Dependent; Nerve Growth Factors; Piperidines; Polyunsaturated Alkamides; Prostatic Neoplasms; Pyrazoles; Receptor Protein-Tyrosine Kinases; Receptors, Cannabinoid; Receptors, Drug; Receptors, Nerve Growth Factor; Receptors, Prolactin; Rimonabant; Tumor Cells, Cultured

2000